Clinical Trial

A Trial of SHR-2173 in Healthy Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic and immunogenicity profile of a single dose of SHR-2173 in healthy participants
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-30
notable Primary completion moved earlier: 2026-08-30 -> 2026-05-22 2026-05-30
Trial Details
NCT Number NCT07390747
Lead Sponsor Atridia Pty Ltd.
Conditions Immunology
Enrollment 18 participants
Start Date 2026-03-06
Primary Completion 2026-05-22 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-29